Evidence map›Paper›PMID 34197081›Full record

ArticleACS applied materials & interfaces2021

Shape-Defined microPlates for the Sustained Intra-articular Release of Dexamethasone in the Management of Overload-Induced Osteoarthritis.

Martina Di Francesco, Sean K Bedingfield, Valentina Di Francesco, Juan M Colazo, Fang Yu, Luca Ceseracciu, Elena Bellotti, Daniele Di Mascolo, Miguel Ferreira, Lauren E Himmel and 2 more

Open access · hybridAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Management of osteoarthritis: From drug molecules to nano/micromedicines.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2022
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Martina Di FrancescoLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia, Via Morego 30, Genoa 16163, Italy.ORCID https://orcid.org/0000-0001-9609-5734
Sean K BedingfieldDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37212, United States.
Valentina Di FrancescoLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia, Via Morego 30, Genoa 16163, Italy.ORCID https://orcid.org/0000-0003-4216-724X
Juan M ColazoDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37212, United States.ORCID https://orcid.org/0000-0002-3591-4246
Fang YuDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37212, United States.
Luca CeseracciuMaterials Characterization Facility, Istituto Italiano di Tecnologia, Via Morego 30, Genova 16163, Italy.ORCID https://orcid.org/0000-0003-3296-8051
Elena BellottiLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia, Via Morego 30, Genoa 16163, Italy.ORCID https://orcid.org/0000-0002-4291-6530
Daniele Di MascoloLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia, Via Morego 30, Genoa 16163, Italy.ORCID https://orcid.org/0000-0002-1422-5775
Miguel FerreiraLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia, Via Morego 30, Genoa 16163, Italy.ORCID https://orcid.org/0000-0002-1560-3571
Lauren E HimmelDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37212, United States.
Craig DuvallDepartment of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37212, United States.ORCID https://orcid.org/0000-0003-3979-0620
Paolo DecuzziLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia, Via Morego 30, Genoa 16163, Italy.ORCID https://orcid.org/0000-0001-6050-4188
Italian Institute of Technology · ITVanderbilt University · USVanderbilt University Medical Center · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Medical Scientist Training ProgramT32GM152284 · NIGMS · VANDERBILT UNIVERSITY · PI Christopher S. Williams · 2024 to 2026
$4.8M
NCI NIH HHS P30 CA068485NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM152284
6 · The paper itself

Abstract

Osteoarthritis (OA) is treated with the intra-articular injection of steroids such as dexamethasone (DEX) to provide short-term pain management. However, DEX treatment suffers from rapid joint clearance. Here, 20 × 10 μm, shape-defined poly(d,l-lactide-co-glycolide)acid microPlates (μPLs) are created and intra-articularly deposited for the sustained release of DEX. Under confined conditions, DEX release is projected to persist for several months, with only ∼20% released in the first month. In a highly rigorous murine knee overload injury model (post-traumatic osteoarthritis), a single intra-articular injection of Cy5-μPLs is detected in the cartilage surface, infrapatellar fat pad/synovium, joint capsule, and posterior joint space up to 30 days. One intra-articular injection of DEX-μPL (1 mg kg

Indexed as

AnimalsBiomarkersCartilage, ArticularDelayed-Action PreparationsDexamethasoneDrug CarriersGene Expression RegulationInjections, Intra-ArticularMiceOsteoarthritisPolylactic Acid-Polyglycolic Acid CopolymerStress, MechanicalBiomarkersDelayed-Action PreparationsDexamethasoneDrug CarriersPolylactic Acid-Polyglycolic Acid Copolymerdrug depotmechanical propertiesosteoarthritispolymeric microparticlessustained release

Identifiers

PMID34197081
PMCPMC8283751
OpenAlexW3173173756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.